samedan logo
 
 
spacer
home > pmps > summer 2019 > why automate?
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Why Automate?

There are many answers to the question 'why automate?', but the bottom line is: if you don’t, you will be left behind. Automation in the pharmaceutical industry affects costs, regulatory compliance, and productivity, so why do we need it?

Data, reproducibility, compliance, and, most importantly, reduction of human error. Can a machine make an error? Of course, it’s called a malfunction. Usually, it is the human who programmed the machine that caused it, so maintenance teams can help provide technical support to make sure the automated process is programmed correctly.

Once the system is set, there are fewer chances for deviation. Automation also provides an opportunity for round-the-clock work because machines do not need to take a break. The benefits of back-up cloud data and encryptions also provide secure systems that can be implemented globally without the need to retrain or reprogram your operations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

spacer
Randice Altschul
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

First own Gerresheimer Autoinjector - Gerresheimer and Midas Pharma announce strategic partnership

– Gerresheimer’s first own IP autoinjector suitable for both small and large molecules enhances broad portfolio of solutions, medical devices and pharmaceutical primary packaging – First joint project of Gerresheimer and Midas Pharma: Development and marketing of new autoinjector – One-stop-shop for biotech and pharma customers Duesseldorf, November 08, 2021 – Gerresheimer acquired the IP of a new generation cartridge based autoinjector from Midas Pharma. This is the start of a strategic partnership. The joint project comprises the development and marketing of the new generation autoinjector.
More info >>

White Papers

Device Develop for Combo Products

Phillips-Medisize

Combination products are defined as therapeutics combining two or more products (drug/device, biologics/device, biologics/drugs or drug/device/biologics), regulated and sold as a single unit. As these pharmaceutical and biological therapies and treatments have evolved, so has the need to develop appropriate delivery mechanisms for these applications. When developing a combination product, there are many things that need to be considered – the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding ‘user’ needs, determining product requirements, as well as, device manufacturing variation.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement